Document is current
Any future updates will be listed below
-
Authors
Singhal, Sandeep K. https://orcid.org/0000-0002-3486-067X
Byun, Jung S.
Park, Samson
Yan, Tingfen
Yancey, Ryan https://orcid.org/0000-0002-4207-0125
Caban, Ambar
Hernandez, Sara Gil
Hewitt, Stephen M.
Boisvert, Heike
Hennek, Stephanie
Bobrow, Mark
Ahmed, Md Shakir Uddin
White, Jason
Yates, Clayton https://orcid.org/0000-0001-5420-9852
Aukerman, Andrew
Vanguri, Rami
Bareja, Rohan
Lenci, Romina https://orcid.org/0000-0002-0025-3134
Farré, Paula Lucia
De Siervi, Adriana
Nápoles, Anna María
Vohra, Nasreen https://orcid.org/0000-0002-6411-3042
Gardner, Kevin https://orcid.org/0000-0001-8018-4353
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA013696, 1R01CA253368, U54 CA118623)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 28 February 2020
Accepted: 29 December 2020
First Online: 1 February 2021
Competing interests
: C.Y. received consulting from QED Therapeutics and Riptide Biosciences. C.Y. owns stock in Riptide Biosciences. The remainder of authors declares no competing interests.
